Welcome! - Multiple Sclerosis News Today
Multiple Sclerosis News Today
Skip to content
  • Home
  • Categories
    • MS Columns
      • Silver Linings
      • Engaging Thoughts
      • The MS Wire
      • Faith of the Mustard Seed
      • You’ve Got Some Nerves
      • Make Change Happen
      • Patiently Awakened
      • Making a Difference
      • A Life in Letters
      • MS in Moderation
      • Fall Down, Get Up Again
      • MS in Motion – A Column by Mike Knight
    • Social Clips
    • RRMS
    • SPMS
    • PPMS
    • Clinical Trials
    • National MS Society
  • About MS
    • What is MS?
      • MS Types
        • Clinically Isolated Syndrome (CIS)
        • Primary Progressive Multiple Sclerosis (PPMS)
        • Relapsing-Remitting Multiple Sclerosis (RRMS)
        • Secondary Progressive Multiple Sclerosis (SPMS)
      • Autoimmune Disease
      • Prognosis and Life Expectancy
      • MS vs. ALS: How Do They Differ?
      • Statistics
    • Healthy Living
      • Physical Exercise
      • Diet & Nutrition
        • Swank Diet
        • McDougall Diet
        • Paleo Diet
        • Mediterranean Diet
        • Gluten-Free Diet
        • Foods to Eat and Avoid
    • Symptoms
      • Early Signs
      • Fatigue
      • Flare-ups
      • Bladder Issues
        • Bladder Problems and MS
        • Bladder Infection
        • Bladder Spasms
        • Neurogenic Bladder
        • Urinary Retention
        • Neurogenic Detrusor Overactivity and MS
        • Overactive Bladder
        • Urinary Incontinence and MS
      • Bowel Incontinence
      • Depression
      • Pain
      • Dysesthesia
      • Heat Intolerance
      • Lhermitte’s sign
      • Sexual Dysfunctions
      • Spasticity
      • The MS hug
      • Uhthoff’s Syndrome
      • Vision Problems
        • Optic Neuritis in Multiple Sclerosis
    • Diagnosis
      • Guidelines for MS diagnosis: McDonald Criteria
      • Magnetic Resonance Imaging (MRI) and MS Diagnosis
      • Evoked Potential (EP) Test and Multiple Sclerosis Diagnosis
      • Spinal Tap Test and Multiple Sclerosis Diagnosis
  • Therapies
    • Trackers
      • RMS Therapy Tracker
      • PMS Therapy Tracker
    • Manage MS Symptoms
      • Fatigue
        • Amantadine For Fatigue
        • Provigil (modafinil)
        • Prozac (fluoxetine)
        • Antivert (meclizine) for Vertigo and Dizziness
      • Bladder Dysfunction
        • Botox (onabotulinumtoxinA)
        • DDAVP Nasal Spray
        • Detrol (tolterodine)
        • Ditropan (oxybutynin) & Ditropan XL
        • Enablex (darifenacin)
        • Flomax (tamsulosin)
        • Hytrin (terazosin)
        • Minipress (prazosin)
        • Oxytrol (oxybutynin)
        • Propantheline
        • Sanctura (trospium chloride)
        • Tofranil (imipramine)
        • Vesicare (solifenacin succinate)
      • Bowel Dysfunction
        • Colace (docusate) for Constipation
        • Dulcolax (bisacodyl)
        • Enemeez (docusate stool softener laxative)
        • Fleet Enema (sodium phosphate) for Constipation
        • Metamucil (psyllium) for Constipation
        • Mineral Oil for Constipation
        • Phillips Milk of Magnesia (magnesium hydroxide) for Constipation
        • Sani-Supp Suppository (glycerin) for Constipation
      • Depression
        • Cymbalta (duloxetine hydrochloride) for Depression
        • Effexor XR (venlafaxine) for Depression
        • Nuedexta (dextromethorphan + quinidine) for PBA
        • Paxil (paroxetine) for Depression
        • Prozac (fluoxetine) for Depression
        • Wellbutrin (bupropion) for Depression
        • Zoloft (sertraline) for Depression
      • Infections
        • Cipro (ciprofloxacin) for UTIs
        • Hiprex (methenamine) for UTIs
        • Macrodantin (nitrofurantoin) for UTIs
      • Muscle Spasms
        • Dantrium (dantrolene)
        • Botox (onabotulinumtoxinA)
        • Gablofen (baclofen – intrathecal)
        • Klonopin – Rivotril – Syn-Clonazepam (clonazepam)
        • Lioresal (baclofen)
        • Nydrazid / Laniazid (isoniazid)
        • Valium (diazepam)
        • Zanaflex (tizanidine)
      • Pain
        • Amitriptyline for Pain Management
        • Atarax (hydroxyzine) for Itching and Burning
        • Deltasone (prednisone) for Relapse Management
        • Dilantin (phenytoin) for Pain Management
        • Klonopin (clonazepam) for Pain Management
        • Neurontin (gabapentin) for Pain Management
        • Pamelor; Aventyl (nortriptyline) for Pain Managemen
        • Pyridium (phenazopyridine) for UTI Pain
        • Tegetrol (carbamazepine) for Pain Management
      • Sexual Dysfunction
        • Cialis (tadalafil) for Erectile Dysfunction
        • Levitra (vardenafil) for Erectile Dysfunction
        • MUSE (alprostadil) for Erectile Dysfunction
        • Papaverine for Erectile Dysfunction
        • Viagra for Erectile Dysfunction & Female Sexual Arousal Disorder
    • Approved Treatments
      • AMPYRA
      • Aubagio
      • Avonex
      • Betaseron
      • Copaxone
      • Decadron
      • Gilenya
      • Extavia
      • Glatopa
      • Lemtrada
      • Novantrone
      • Tecfidera
      • Ocrevus
      • Rebif (interferon beta-1a)
      • Plegridy
      • Solu-Medrol
      • Tysabri (Natalizumab)
      • Zinbryta (Daclizumab)
    • Assistive Devices for Multiple Sclerosis
      • SafeGait 360 Balance and Mobility Trainer
      • External Urethral Barrier
      • ReWalk for Multiple Sclerosis
    • RRMS Therapies
    • Stem Cell Therapy
      • aHSCT – Autologous Hemopoietic Stem Cell Transplantation in MS
      • Different Types of Stem Cells
      • Stem Cell Clinical Trials and MS
        • Mesenchymal Stem Cell (MSCT) Clinical Trials
        • Neuron Stem Cell (NSC) Clinical Trials
      • How are Stem Cells Regulated?
    • Experimental Treatments
      • ALKS 8700
      • AP-1
      • Midamor (Amiloride) for PPMS and SPMS
      • Amiselimod (MT-1303)
      • Anti-LINGO-1 / BIIB033 / Opicinumab
      • APD334
      • ATL1102
      • ATX-MS-1467
      • BN201
      • Cladribine
      • Dalazatide (Formerly ShK-186)
      • Dysport (abobotulinumtoxin A) for Overactive Bladder
      • CTP-354
      • GIFT-15
      • GLX1112
      • GNbAC1
      • Ibudilast (MN-166)
      • IkT-001Pro
      • Laquinimod (Nerventra, ABR-215062) for PPMS
      • Lisinopril
      • Lipoic Acid
      • Masitinib (AB1010)
      • Minocycline
      • MD1003
      • MEDI-551
      • MIS416 for SPMS
      • NDC-1308
      • Ofatumumab (Arzerra)
      • Ozanimod (Formerly RPC1063)
      • PDA-001
      • Ponesimod
      • Raltegravir (isentress)
      • Raxone (Idebenone) for PPMS
      • Rituximab
      • RHB-104
      • rHIgM22
      • Riluzole for PPMS and SPMS
      • RPI-78M
      • RTL1000
      • Simvastatin for SPMS
      • Siponimod (BAF312) for SPMS
      • Tcelna
      • Vatelizumab (GBR 500)
      • Vitamin D
      • Zenapax
  • Forums

Welcome!

September 9, 2016September 9, 2016
Michael Naceby Michael Nace

Home » Welcome!

Thank you for subscribing to our tri-weekly e-newsletter! You will now receive three e-newsletters per week — a Monday “news” newsletter, a Wednesday “columns” newsletter, and a Friday “social media” newsletter.

Read the latest news on Relapsing Multiple Sclerosis.



Never Miss Another MS Update! Receive Our Free Newsletter.

* indicates required

Featured Posts

  • anniversary Marking the 1-year Anniversary of ‘MS In Motion’
  • Phase 3 PARADIGMS trial #AAN2018 – Review of Phase 3 Trial Data Supports Gilenya as Treatment for Pediatric MS
  • ALKS 8700 for RRMS #AAN2018 — ALKS 8700 Shows Promise as RRMS Therapy, Phase 3 Trial Interim Results Suggest
  • This Was Me Before Multiple Sclerosis: A Letter to MS

MS News

BioNews Services, LLC
5307 E. Mockingbird Ln.
5th Floor
Dallas, TX 75206
Email: [email protected]
Phone: 1-800-936-1363

BioNews Feed

Recent Posts

  • anniversary

    Marking the 1-year Anniversary of ‘MS In Motion’

    April 25, 2018

  • Phase 3 PARADIGMS trial

    #AAN2018 – Review of Phase 3 Trial Data Supports Gilenya as Treatment for Pediatric MS

    April 25, 2018

  • ALKS 8700 for RRMS

    #AAN2018 — ALKS 8700 Shows Promise as RRMS Therapy, Phase 3 Trial Interim Results Suggest

    April 25, 2018

  • This Was Me Before Multiple Sclerosis: A Letter to MS

    April 24, 2018

  • About MS News Today
  • Contact Us
  • Privacy Policy
  • Terms of Service
  • Advertise

Disclaimer:

Multiple Sclerosis News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.
Copyright © 2013-2018 All rights reserved n

Pin It on Pinterest

Share This
  • Facebook
  • Twitter
  • Google+
  • Pinterest
  • LinkedIn
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. We never use your cookies for creepy ad retargeting that follows you around the web. OkRead more